Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 / NO16966, a randomized phase III trial in first-line metastatic colorectal…

XELOX-1/NO16966, a randomized phase III trial of first-line XELOX vs. FOLFOX-4 for patients with metastatic colorectal cancer (MCRC): Updated overall survival results Cassidy…

BOPA 2009 Clinical Update: Colorectal Cancer Dr Nick Maisey Treatment Intent Adjuvant Palliative ADJUVANT CHEMOTHERAPY Moertel et al, 1990 / 1995 CALGB 89803. Saltz et al…

XELOX vs. FOLFOX4: survival and response results from XELOX-1 / NO16966, a randomized phase III trial of first-line treatment for patients with metastatic colorectal cancer…

BOPA 2009 Clinical Update: Colorectal Cancer Dr Nick Maisey Treatment Intent Adjuvant Palliative ADJUVANT CHEMOTHERAPY Moertel et al, 1990 / 1995 CALGB 89803. Saltz et al…

A Report from ASCO 2007 First-Line Metastatic Colorectal Cancer Edward Chu, MD Professor, Medicine & Pharmacology Chief, Section of Medical Oncology Deputy Director,…